System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid

Nuclear Medicine and Biology

Volumn 42, Issue 1, 2015, Pages 8-18

  Yu, Weiping ^a   McConathy, Jonathan ^b   Olson, Jeffrey J ^a   Goodman, Mark M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fluorine 18; PET; System A amino acid transport; Tumor imaging; 18F FAMP; 18F MeFAMP

Indexed keywords

2 AMINO 3 FLUORO 2 METHYLPROPIONIC ACID F 18; 3 FLUORO 2 METHYL 2 (METHYLAMINO)PROPIONIC ACID F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 2 AMINO 2 METHYLPROPIONIC ACID; 2-AMINO-3-FLUORO-2-METHYLPROPANOIC ACID; 3-FLUORO-2-METHYL-2-(METHYLAMINO)PROPANOIC ACID; BRANCHED CHAIN AMINO ACID; PROPIONIC ACID; PROPIONIC ACID DERIVATIVE;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN TISSUE; BREAST CANCER; CANCER CELL LINE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG SELECTIVITY; DRUG TARGETING; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; DRUG UPTAKE; ENANTIOMER; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; ISOTOPE TRACING; KIDNEY PARENCHYMA; MOUSE; NEUROIMAGING; NON SMALL CELL LUNG CANCER; NONHUMAN; OVARY CANCER; PANCREAS; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; RADIOISOTOPE DIAGNOSIS; RADIOISOTOPE DISTRIBUTION; SPLEEN; TISSUE DISTRIBUTION; TUMOR XENOGRAFT; ANIMAL; BRAIN; CHEMISTRY; METABOLISM; PROCEDURES; SCINTISCANNING; STEREOISOMERISM; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

AMINO ACIDS, BRANCHED-CHAIN; AMINOISOBUTYRIC ACIDS; ANIMALS; BIOLOGICAL TRANSPORT; BRAIN; CELL LINE, TUMOR; HUMANS; MICE; POSITRON-EMISSION TOMOGRAPHY; PROPIONATES; STEREOISOMERISM;

EID: 84920412788     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2014.07.002     Document Type: Article

References (48)

1. American Cancer Society http://www.cancer.org.
2. Huang C., McConathy J. Radiolabeled amino acids for oncologic imaging. J Nucl Med 2013, 54:1007-1010.
3. McConathy J., Yu W., Jarkas N., Seo W., Schuster D.M., Goodman M.M. Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents. Med Res Rev 2012, 32:868-905.
4. Strauss L.G. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996, 23:1409-1415.
5. Chun E.J., Lee H.J., Kang W.J., Kim K.G., Goo J.M., Park C.M., et al. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT. Lung Cancer 2009, 65:180-186.
6. Divgi C.R. Molecular imaging of pulmonary cancer and inflammation. Proc Am Thorac Soc 2009, 6:464-468.
7. Shim S.S., Lee K.S., Kim B.T., Choi J.Y., Chung M.J., Lee E.J. Focal parenchymal lung lesions showing a potential of false-positive and false-negative interpretations on integrated PET/CT. AJR Am J Roentgenol 2006, 186:639-648.
8. Acker M.R., Burrell S.C. Utility of 18F-FDG PET in evaluating cancers of lung. J Nucl Med Technol 2005, 33:69-74. [quiz 5-7].
9. Sutinen E., Jyrkkio S., Alanen K., Nagren K., Minn H. Uptake of [N-methyl-11C]alpha-methylaminoisobutyric acid in untreated head and neck cancer studied by PET. Eur J Nucl Med Mol Imaging 2003, 30:72-77.
10. Nishii R., Higashi T., Kagawa S., Kishibe Y., Takahashi M., Yamauchi H., et al. Diagnostic usefulness of an amino acid tracer, alpha-[N-methyl-C]-methylaminoisobutyric acid (C-MeAIB), in the PET diagnosis of chest malignancies. Ann Nucl Med 2013, 27:808-821.
11. 11C-choline. J Nucl Med 2011, 52:81-89.
12. Jager P.L., Vaalburg W., Pruim J., de Vries E.G., Langen K.J., Piers D.A. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001, 42:432-445.
13. Laverman P., Boerman O.C., Corstens F.H., Oyen W.J. Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med 2002, 29:681-690.
14. Leskinen-Kallio S., Huovinen R., Nagren K., Lehikoinen P., Ruotsalainen U., Teras M., et al. [11C]methionine quantitation in cancer PET studies. J Comput Assist Tomogr 1992, 16:468-474.
15. Leskinen-Kallio S., Nagren K., Lehikoinen P., Ruotsalainen U., Teras M., Joensuu H. Carbon-11-methionine and PET is an effective method to image head and neck cancer. J Nucl Med 1992, 33:691-695.
16. Inoue T., Kim E.E., Wong F.C., Yang D.J., Bassa P., Wong W.H., et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors. J Nucl Med 1996, 37:1472-1476.
17. Crippa F., Alessi A., Serafini G.L. PET with radiolabeled aminoacid. Q J Nucl Med Mol Imaging 2012, 56:151-162.
18. Galldiks N., Stoffels G., Filss C.P., Piroth M.D., Sabel M., Ruge M.I., et al. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med 2012, 53:1367-1374.
19. 18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2006, 33:287-294.
20. Stout D.B., Huang S.C., Melega W.P., Raleigh M.J., Phelps M.E., Barrio J.R. Effects of large neutral amino acid concentrations on 6-[F-18]Fluoro-L-DOPA kinetics. J Cereb Blood Flow Metab 1998, 18:43-51.
21. Becherer A., Karanikas G., Szabo M., Zettinig G., Asenbaum S., Marosi C., et al. Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine. Eur J Nucl Med Mol Imaging 2003, 30:1561-1567.
22. Bussolati O., Uggeri J., Belletti S., Dall'Asta V., Gazzola G.C. The stimulation of Na, K, Cl cotransport and of system A for neutral amino acid transport is a mechanism for cell volume increase during the cell cycle. FASEB J 1996, 10:920-926.
23. Dawson W.D., Cook J.S. Parallel changes in amino acid transport and protein kinase C localization in LLC-PK1 cells treated with TPA or diradylglycerols. J Cell Physiol 1987, 132:104-110.
24. Boerner P., Saier M.H. Effects of 5-azacytidine, sodium butyrate, and phorbol esters on amino acid transport system A in a kidney epithelial cell line, MDCK: evidence for multiple mechanisms of regulation. J Cell Physiol 1988, 137:117-124.
25. Guidotti G.G., Borghetti A.F., Gazzola G.C. The regulation of amino acid transport in animal cells. Biochim Biophys Acta 1978, 515:329-366.
26. Kilberg M.S., Barber E.F., Handlogten M.E. Characteristics and hormonal regulation of amino acid transport system A in isolated rat hepatocytes. Curr Top Cell Regul 1985, 25:133-163.
27. Kilberg M.S., Bracy D.S., Handlogten M.E. Substrate regulation of hepatic system A transport activity after induction by substrate starvation or glucagon. Fed Proc 1986, 45:2438-2441.
28. Soler C., Felipe A., Casado F.J., McGivan J.D., Pastor-Anglada M. Hyperosmolarity leads to an increase in derepressed system A activity in the renal epithelial cell line NBL-1. Biochem J 1993, 289(Pt 3):653-658.
29. Kondoh N., Imazeki N., Arai M., Hada A., Hatsuse K., Matsuo H., et al. Activation of a system A amino acid transporter, ATA1/SLC38A1, in human hepatocellular carcinoma and preneoplastic liver tissues. Int J Oncol 2007, 31:81-87.
30. Qian N.X., Pastor-Anglada M., Englesberg E. Evidence for coordinate regulation of the A system for amino acid transport and the mRNA for the alpha 1 subunit of the Na+, K(+)-ATPase gene in Chinese hamster ovary cells. Proc Natl Acad Sci U S A 1991, 88:3416-3420.
31. Yu W.L., Cong W.M., Zhang Y., Chen Y., Wang F., Yu G. Overexpression of ATA1/SLC38A1 predicts future recurrence and death in Chinese patients with hilar cholangiocarcinoma. J Surg Res 2011, 171:663-668.
32. Wang K., Cao F., Fang W., Hu Y., Chen Y., Ding H., et al. Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpression. BMC Cancer 2013, 13:343.
33. Schwarzbach M., Willeke F., Dimitrakopoulou-Strauss A., Strauss L.G., Zhang Y.M., Mechtersheimer G., et al. Functional imaging and detection of local recurrence in soft tissue sarcomas by positron emission tomography. Anticancer Res 1999, 19:1343-1349.
34. Sutinen E., Jyrkkio S., Gronroos T., Haaparanta M., Lehikoinen P., Nagren K. Biodistribution of [11C] methylaminoisobutyric acid, a tracer for PET studies on system A amino acid transport in vivo. Eur J Nucl Med 2001, 28:847-854.
35. Yu W., McConathy J., Williams L., Camp V.M., Malveaux E.J., Zhang Z., et al. Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging brain tumors. J Med Chem 2010, 53:876-886.
36. McConathy J., Martarello L., Malveaux E.J., Camp V.M., Simpson N.E., Simpson C.P., et al. Radiolabeled amino acids for tumor imaging with PET: radiosynthesis and biological evaluation of 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid. J Med Chem 2002, 45:2240-2249.
37. Yu W., Williams L., Camp V.M., Malveaux E., Olson J.J., Goodman M.M. Stereoselective synthesis and biological evaluation of syn-1-amino-3-[18F]fluorocyclobutyl-1-carboxylic acid as a potential positron emission tomography brain tumor imaging agent. Bioorg Med Chem 2009, 17:1982-1990.
38. Yu W., Williams L., Camp V.M., Olson J.J., Goodman M.M. Synthesis and biological evaluation of anti-1-amino-2-[18F]fluoro-cyclobutyl-1-carboxylic acid (anti-2-[18F]FACBC) in rat 9L gliosarcoma. Bioorg Med Chem Lett 2010, 20:2140-2143.
39. Palacin M., Estevez R., Bertran J., Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev 1998, 78:969-1054.
40. Broer S. Amino acid transport across mammalian intestinal and renal epithelia. Physiol Rev 2008, 88:249-286.
41. Deves R., Boyd C.A. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 1998, 78:487-545.
42. Benrabh H., Lefauconnier J.M. Blood-endothelial cell and blood-brain transport of L-proline, alpha-aminoisobutyric acid, and L-alanine. Neurochem Res 1996, 21:1227-1235.
43. Heiss P., Mayer S., Herz M., Wester H.J., Schwaiger M., Senekowitsch-Schmidtke R. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 1999, 40:1367-1373.
44. Bourdier T., Shepherd R., Berghofer P., Jackson T., Fookes C.J., Denoyer D., et al. Radiosynthesis and biological evaluation of L- and D-S-(3-[18F]fluoropropyl)homocysteine for tumor imaging using positron emission tomography. J Med Chem 2011, 54:1860-1870.
45. Yu W., McConathy J., Olson J., Camp V.M., Goodman M.M. Facile stereospecific synthesis and biological evaluation of (S)- and (R)-2-amino-2-methyl-4-[123I]iodo-3-(E)-butenoic acid for brain tumor imaging with single photon emission computerized tomography. J Med Chem 2007, 50:6718-6721.
46. Ikotun O.F., Marquez B.V., Huang C., Masuko K., Daiji M., Masuko T., et al. Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET. PLoS One 2013, 8:e77476.
47. Schmall B., Conti P.S., Bigler R.E., Zanzonico P.B., Dahl J.R., Sundoro-Wu B.M., et al. Synthesis and quality assurance of [11C]alpha-aminoisobutyric acid (AIB), a potential radiotracer for imaging and amino acid transport studies in normal and malignant tissues. Int J Nucl Med Biol 1984, 11:209-214.
48. Shoup T.M., Olson J., Hoffman J.M., Votaw J., Eshima D., Eshima L., et al. Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors. J Nucl Med 1999, 40:331-338.